research Letter on: “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life”
Platelet-rich plasma treatment for hair loss may improve patients' quality of life.
Search
for
Sort by
Research
900-930 / 1000+ results 
research Alopecia: An OVerall Review Including Causes, COVID-19, Diet, And Treatments
The document concludes that alopecia is an incurable autoimmune disease with various treatments and that diet, as well as COVID-19, may impact it.
research Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
COVID-19 can cause long-term skin problems and has changed how skin doctors work.
research Incidence and probable risk factors of post COVID syndrome among COVID-19 patients in urban population of North Kerala: a 6 months cohort study
Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.
research Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.
research Alopecia and COVID-19: possible etiopathogenetic variants and therapeutic approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Acute Telogen Effluvium: A Post-COVID-19 Sequela
COVID-19 infection may cause hair loss.
research Eflúvio Telógeno pós-COVID: uma revisão integrativa
COVID-19 can cause temporary hair loss.
research A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19
COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.
research Telogen Effluvium After COVID-19 Infection: A Case Report
COVID-19 infection may cause hair loss a few months after recovery.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.
research JAMA Dermatology—The Year in Review, 2021
In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.
research Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Потеря волос, ассоциированная с COVID‑19: проблема и пути решения
COVID-19 can cause temporary hair loss due to stress and inflammation.
research 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
research Complementary, Holistic, and Integrative Medicine
Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.
research Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
COVID-19 can cause skin problems.
research Post-COVID-19 Syndrome Mechanisms, Prevention and Management
Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.
research Alopecia in patients with COVID-19: A systematic review and meta-analysis
Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.
research Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region
People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.
research Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
The method effectively predicts new drug uses, including potential COVID-19 treatments.
research Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
Nearly half of the studied men with long COVID had low testosterone, including younger men.
research Effective holistic characterization of small molecule effects using heterogeneous biological networks
Integrating biological networks improves drug repurposing and ADR prediction.
research Exosomes in stroke management: A promising paradigm shift in stroke therapy
Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.
research Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.